Selective Janus kinase inhibitors come of age

被引：59
|
作者：
O'Shea, John J. [1 ]
Gadina, Massimo [2 ]
机构：
[1] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA
[2] NIAMSD, Translat Immunol Sect, Bethesda, MD 20892 USA
来源：
NATURE REVIEWS RHEUMATOLOGY | 2019年 / 15卷 / 02期
关键词：
D O I：
10.1038/s41584-018-0155-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Janus kinase (JAK) inhibitors (jakinibs) that target downstream signalling by a large range of cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that selectively inhibit individual JAKs and a narrower spectrum of cytokines have now been developed, but how do these inhibitors compare with existing drugs?
引用
收藏
页码：74 / 75
页数：3
相关论文
共 50 条
  • [1] Selective Janus kinase inhibitors come of age
    John J. O’Shea
    Massimo Gadina
    Nature Reviews Rheumatology, 2019, 15 : 74 - 75
  • [2] Development of Selective Covalent Janus Kinase 3 Inhibitors
    Tan, Li
    Akahane, Koshi
    McNally, Randall
    Reyskens, Kathleen M. S. E.
    Ficarro, Scott B.
    Liu, Suhu
    Herter-Sprie, Grit S.
    Koyama, Shohei
    Pattison, Michael J.
    Labella, Katherine
    Johannessen, Liv
    Akbay, Esra A.
    Wong, Kwok-Kin
    Frank, David A.
    Marto, Jarrod A.
    Look, Thomas A.
    Arthur, J. Simon C.
    Eck, Michael J.
    Gray, Nathanael S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (16) : 6589 - 6606
  • [3] Janus kinase inhibitors clear to land Janus kinase inhibitors in RA
    Aringer, Martin
    RHEUMATOLOGY, 2018, 57 (07) : 1131 - 1132
  • [4] Selective Janus kinase inhibitors: Promising drugs for rheumatoid arthritis
    Zanwar, Abhishek
    Aggarwal, Amita
    NATIONAL MEDICAL JOURNAL OF INDIA, 2019, 32 (02): : 96 - +
  • [5] Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
    Hanan, Emily J.
    van Abbema, Anne
    Barrett, Kathy
    Blair, Wade S.
    Blaney, Jeff
    Chang, Christine
    Eigenbrot, Charles
    Flynn, Sean
    Gibbons, Paul
    Hurley, Christopher A.
    Kenny, Jane R.
    Kulagowski, Janusz
    Lee, Leslie
    Magnuson, Steven R.
    Morris, Claire
    Murray, Jeremy
    Pastor, Richard M.
    Rawson, Tom
    Siu, Michael
    Ultsch, Mark
    Zhou, Aihe
    Sampath, Deepak
    Lyssikatos, Joseph P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10090 - 10107
  • [6] Selective inhibitors of the Janus kinase Jak3-Are they effective?
    Thoma, Gebhard
    Drueckes, Peter
    Zerwes, Hans-Guenter
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (19) : 4617 - 4621
  • [7] Janus kinase inhibitors
    Ostermeier, E.
    Roll, P.
    Tony, H. -P.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (06): : 473 - 478
  • [8] Janus kinase inhibitors
    Witte, Torsten
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (02): : 94 - 99
  • [9] Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors
    Schenkel, Laurie B.
    Huang, Xin
    Cheng, Alan
    Deak, Holly L.
    Doherty, Elizabeth
    Emkey, Renee
    Gu, Yan
    Gunaydin, Hakan
    Kim, Joseph L.
    Lee, Josie
    Loberg, Robert
    Olivieri, Philip
    Pistillo, Jeanne
    Tang, Jin
    Wan, Qian
    Wang, Hui-Ling
    Wang, Shen-Wu
    Wells, Mary C.
    Wu, Bin
    Yu, Violeta
    Liu, Liqin
    Geuns-Meyer, Stephanie
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (24) : 8440 - 8450
  • [10] Pharmacology of Janus kinase inhibitors
    Solimani, F.
    Hilke, F. J.
    Ghoreschi, K.
    HAUTARZT, 2019, 70 (12): : 934 - 941
12345